Investors are increasingly betting that “China is back” as the economy rebounds from years of deflation, helped by strong manufacturing, ex...

American business leaders are heading to China for a summit with President Xi Jinping. They aim to resolve ongoing business challenges and ...

Kiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...

Geopolitical tensions in West Asia are manageable now. However, a prolonged US-Israel war against Iran could raise costs for petrochemical-...

The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...

Sun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...

Kailera Therapeutics shares surged 62.5% in their Nasdaq debut after raising $625 million in a U.S. IPO priced at the top end of its range....

Dheeraj Chinthalapelly, with a decade and a half of experience in global capital markets, shares his journey navigating the biotech investm...

Gilead is making headlines with its planned acquisition of Tubulis GmbH, a Germany-based company, for a maximum of five billion dollars. Th...

Why US stock market crashes today? Dow Jones, S&P 500 and Nasdaq in deep red today. Wall Street turns sharply lower as US stock market cras...

Anthropic acquires startup Coefficient Bio for about $400 million: report

Rossari will initially acquire 65 per cent equity stake in Unitop Chemicals, while the remainder 35 per cent stake will be bought over the ...

JC Biotech currently commands a 50%+ share in the Indian market, thereby taking Advanced Enzymes’ combined market share to 80%+ post acquis...

Drug maker Cipla on Tuesday said it will invest USD 65 million (nearly Rs 300 crore) over the next three years with a Chinese joint venture...

Leading Indian healthcare major Zydus Cadila said in a regulatory statement here Tusday that it has acquired Italy-based Etna Biotech, a wh...

Vincent Aita of Kilkenny Capital Management says he picks biotechnology stocks on their potential as takeover targets.

India’s largest drug maker by size, Ranbaxy, is scouting for a biotech acquisition that will give it a strong presence in the global biopha...